The National Institute of Health (NIH) is clearly communicating that it plans to find a way to fix the deficiencies found last month at its “Pharmaceutical Development Section” by FDA. Although this is a major step back for the organization, it has already created a Remediation plan to fix the situation. This plan consists of two parts; NIH Interim Corrective Action Plan PDS and NIH Interim Corrective Action Plan Pharmacy.

NIH hopes to make all of the necessary corrections to its facility by September 2015. To find out more about the deficiencies found by FDA and NIH Remediation plan, click here.